CRESCENT BIOPHARMA INC.: Ownership & Insider Activity
Hedge funds and institutional managers reporting a position in CRESCENT BIOPHARMA INC.. Based on the most recent 13F filing from each holder, sourced from SEC EDGAR.
Reported Holders
8
13F filers
Aggregate Value
$52.4M
Across holders
Last Price
—
EOD close
Sector
—
GICS
| Manager⇅ | Type⇅ | Shares⇅ | Market Value▼ | % of Total⇅ | % of Portfolio⇅ | Action⇅ | QoQ Change⇅ | Quarter⇅ |
|---|---|---|---|---|---|---|---|---|
| BALYASNY ASSET MANAGEMENT LLC CIK 0001218710 | Hedge Fund | 1.66M | $29.9M | 57.1% | 0.0% | Added | +$2.8M | Q2 2026 |
| MILLENNIUM MANAGEMENT LLC CIK 0001273087 | Hedge Fund | 404K | $7.3M | 13.9% | 0.0% | Added | +$1.4M | Q2 2026 |
| Point72 Asset Management, L.P. CIK 0001603466 | Hedge Fund | 300K | $5.4M | 10.3% | 0.0% | Unchanged | +$0 | Q2 2026 |
| MARSHALL WACE, LLP CIK 0001318757 | Hedge Fund | 214K | $3.9M | 7.4% | 0.0% | Added | $-1.0M | Q2 2026 |
| TWO SIGMA INVESTMENTS, LP CIK 0001179392 | Hedge Fund | 187K | $3.4M | 6.4% | 0.0% | Added | +$1.3M | Q2 2026 |
| Woodline Partners LP CIK 0001784547 | Hedge Fund | 94K | $1.7M | 3.2% | 0.0% | Added | +$369K | Q2 2026 |
| MOORE CAPITAL MANAGEMENT, LP CIK 0001448574 | Hedge Fund | 25K | $450K | 0.9% | 0.0% | Unchanged | +$0 | Q2 2026 |
| Squarepoint Ops LLC CIK 0001642575 | Hedge Fund | 24K | $435K | 0.8% | 0.0% | New | — | Q2 2026 |
Added
Hedge Fund
$29.9M· 57.1% of total· 0.0% port· 1.66M sh· +$2.8M QoQ· Q2 2026
Added
Hedge Fund
$7.3M· 13.9% of total· 0.0% port· 404K sh· +$1.4M QoQ· Q2 2026
Unchanged
Hedge Fund
$5.4M· 10.3% of total· 0.0% port· 300K sh· +$0 QoQ· Q2 2026
Added
Hedge Fund
$3.9M· 7.4% of total· 0.0% port· 214K sh· $-1.0M QoQ· Q2 2026
Added
Hedge Fund
$3.4M· 6.4% of total· 0.0% port· 187K sh· +$1.3M QoQ· Q2 2026
Added
Hedge Fund
$1.7M· 3.2% of total· 0.0% port· 94K sh· +$369K QoQ· Q2 2026
Unchanged
Hedge Fund
$450K· 0.9% of total· 0.0% port· 25K sh· +$0 QoQ· Q2 2026
New
Hedge Fund
$435K· 0.8% of total· 0.0% port· 24K sh· — QoQ· Q2 2026